The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
A foolish faith in authority is the worst enemy of truth."― Albert Einstein. The company offers a variety of products urged in surgery including its proprietary minimally invasive surgical implant ...
SI-BONE reports strong revenue growth and improved financial metrics for Q4 2024 and FY 2024, achieving positive adjusted EBITDA. SI-BONE, Inc. reported strong financial results for the fourth quarter ...
Hosted on MSN
SI-BONE outlines 14%-16% revenue growth for 2026 with new product launches and Smith & Nephew partnership
Laura Francis, CEO & Director, stated that "our strong fourth quarter and full year 2025 results validate that our innovation-led growth strategy is delivering meaningful real-world impact." She ...
(Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced U.S. Food and Drug Administration (FDA) 510(k) ...
Hosted on MSN
Why Si-Bone stock soared by almost 20% on Tuesday
It posted rather encouraging first-quarter results. It also raised (albeit modestly) certain full-year guidance items. 10 stocks we like better than SI-Bone › On Tuesday, Si-Bone (NASDAQ: SIBN) stock ...
Maheshwari announced, "We're updating our full year revenue guidance to range between $198 million to $200 million. This implies year-over-year growth of approximately 18% to 20% as compared to the ...
SANTA CLARA, Calif., Aug. 31, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised ...
SI-Bone took the wraps off its third-quarter numbers just after market close on Monday, divulging that its revenue was $48.7 million for the period. That represented a very healthy year-over-year ...
Fuse TORQ implants from specific lots whose tube packaging had been manufactured between May 4, 2026 and May 15, 2026 and which had been distributed to the Company's field salesforce and its customers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results